Update in Hematology: Graft-versus-Host Disease


Related Videos (117)

David L. Porter, MD discusses the treatment algorithims in use at Penn Medicine and the Abramson Cancer Center to minimize the effects of graft-versus-host disease, one of the severe and debilitating effects of chemotherapy in patients with hematological cancers.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®